Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baxter International (BAX)
NYSE:BAX
Holding BAX?
Track your performance easily
BAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$31.01 - $44.01
Previous Close$39.37
Volume983.66K
Average Volume (3M)4.52M
Market Cap
$19.79B
Enterprise Value$31.39B
Total Cash (Recent Filing)$2.10B
Total Debt (Recent Filing)$13.34B
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Oct 24, 2024EPS Estimate
$0.78Last Dividend Ex-Date
Aug 30, 2024Dividend Yield2.91%
Share Statistics
EPS (TTM)-0.80
Shares Outstanding510,177,606
10 Day Avg. Volume3,818,311
30 Day Avg. Volume4,516,456
Standard Deviation0.08
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.63
Price to Sales (P/S)1.35
Price to Cash Flow (P/CF)44.20
P/FCF Ratio40.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.09
Enterprise Value/Gross Profit6.31
Enterprise Value/Ebitda19.50
Forecast
1Y Price Target
$42.20Price Target Upside8.79% Upside
Rating ConsensusHold
Number of Analyst Covering12
Baxter International News
PremiumCompany Announcements
Baxter International Welcomes Jeffrey A. Craig to Board
PremiumCompany Announcements
Baxter International Senior Financial Officer Resigns
PremiumCompany Announcements
Baxter International Divests Renal Care in Strategic ShiftBulls Say, Bears Say
Bulls Say
Divestiture ImpactBAX's divestiture of Vantive to Carlyle for $3.8 billion is expected to accelerate debt reduction and boost top-line growth.
Financial PerformanceQ2 revenue and EPS of $3.81 billion and $0.68 beat guidance and Street forecasts, indicating strong financial performance.
Revenue GrowthBAX is highly confident in achieving 4-5% revenue growth long term and getting back to 19-20% operating margins.
Bears Say
EarningsPost-spin 2025 EPS looks slightly lower than expected given the 2025 operating margin of 16.5% shows little underlying margin expansion.
Financial Performance2024 RemainCo segment margins which are contracting 130-140 basis points year-over-year in the first half are not a good reflection of 2025’s margin expansion opportunity.
Stock PerformanceBAX stock down 6.5% as dilution on the Vantive divestiture came in higher vs expectations.
---
Ownership Overview
5.52% Insiders
39.84% Mutual Funds
52.24% Other Institutional Investors
2.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BAX FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest stock price was $31.01 and its highest was $44.01 in the past 12 months.
What is Baxter International’s market cap?
Currently, no data Available
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is Oct 24, 2024 which is in 35 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on Aug 06, 2024. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.662 by $0.018.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 2.91%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is $0.78.
How many shares outstanding does Baxter International have?
Baxter International has 510,177,600 shares outstanding.
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of $0.68 in its last earnings report, beating expectations of $0.662. Following the earnings report the stock price went up 6.574%.
Which hedge fund is a major shareholder of Baxter International?
Among the largest hedge funds holding Baxter International’s share is Pzena Investment Management LLC. It holds Baxter International’s shares valued at 1B.
---
Baxter International Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$42.20 (8.79% Upside)
$42.20 (8.79% Upside)
Blogger Sentiment
Bullish
BAX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 7.3%
Last 30 Days ▼ 7.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.89%
12-Months-Change
Fundamentals
Return on Equity
-2.38%
Trailing 12-Months
Asset Growth
-5.64%
Trailing 12-Months
Company Description
Baxter International
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
---
BAX Company Deck
---
BAX Earnings Call
Q2 2024
0:00 / 0:00
---
BAX Net sales Breakdown
33.83% Medical Products and Therapies
30.06% Kidney Care
20.34% Healthcare Systems and Technologies
15.18% Pharmaceuticals
0.59% Other
---
BAX Stock 12 Month Forecast
Average Price Target
$42.20
▲(8.79% Upside)
Technical Analysis
Best Analysts Covering BAX
1 Year
1 Year Success Rate
9/21 ratings generated profit
1 Year Average Return
-2.93%
reiterated a buy rating 2 months ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -2.93% per trade.
---